View in EDS

Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
Authors: Sweet K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. kendra.sweet@moffitt.org., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Cubitt CL; Department of Translational Research, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Turner JG; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Zhou J; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., List AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Dawson JL; Department of Experimental Therapeutics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Sullivan DM; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Chavez J; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Shah BD; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 54-60. Date of Electronic Publication: 2019 Oct 21.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31636097
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sweet+K%22">Sweet K</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. kendra.sweet@moffitt.org.<br /><searchLink fieldCode="AU" term="%22Komrokji+R%22">Komrokji R</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Padron+E%22">Padron E</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Cubitt+CL%22">Cubitt CL</searchLink>; Department of Translational Research, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Turner+JG%22">Turner JG</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22List+AF%22">List AF</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Sallman+DA%22">Sallman DA</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Dawson+JL%22">Dawson JL</searchLink>; Department of Experimental Therapeutics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Sullivan+DM%22">Sullivan DM</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Chavez+J%22">Chavez J</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Shah+BD%22">Shah BD</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Lancet+JE%22">Lancet JE</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 54-60. <i>Date of Electronic Publication: </i>2019 Oct 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31636097
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-19-2169
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 54
    Titles:
      – TitleFull: Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sweet K
      – PersonEntity:
          Name:
            NameFull: Komrokji R
      – PersonEntity:
          Name:
            NameFull: Padron E
      – PersonEntity:
          Name:
            NameFull: Cubitt CL
      – PersonEntity:
          Name:
            NameFull: Turner JG
      – PersonEntity:
          Name:
            NameFull: Zhou J
      – PersonEntity:
          Name:
            NameFull: List AF
      – PersonEntity:
          Name:
            NameFull: Sallman DA
      – PersonEntity:
          Name:
            NameFull: Dawson JL
      – PersonEntity:
          Name:
            NameFull: Sullivan DM
      – PersonEntity:
          Name:
            NameFull: Chavez J
      – PersonEntity:
          Name:
            NameFull: Shah BD
      – PersonEntity:
          Name:
            NameFull: Lancet JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020 Jan 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1